Hepratide

贺普拉肽

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameHepratide
Drug Alias NameHe Pula PeptideHepalatideN-tideL-47
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSodium/bile acid cotransporter inhibitors
TargetsSodium/bile acid cotransporter
Therapy Area/IndicationsHepatitis D, ChronicHepatitis DHepatitis C, Chronic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMongoliaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai HEP Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai HEP Pharmaceutical Co LtdShanghai Hepu Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis D, ChronicHepatitis DHepatitis C, Chronic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A